Home › Funds › Artia Global Partners LP › SION
Artia Global Partners LP position in SION
SIONNA THERAPEUTICS INC · Health Care
Artia Global Partners LP reported holding 119,741 shares of SION (SIONNA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$5.3M, representing 0.97% of its reported portfolio and ranking #26 among its reported holdings. Artia Global Partners LP has disclosed SION holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Artia Global Partners LP's SION position evolved
Artia Global Partners LP first disclosed a stake in SION in Q4 2025 at 119,741 shares (US$4.9M). The position peaked in Q2 2026 at 119,741 shares, worth US$5.3M. Across 3 filings, Artia Global Partners LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 119,741 shares valued at US$5.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 119.74K | $4.93M | New |
| Q1 2026 | 119.74K | $4.80M | Hold |
| Q2 2026 | 119.74K | $5.27M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SION and 13F data
SION (SIONNA THERAPEUTICS INC) is a Health Care company. 86 other funds we track also report a position in SION — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$435.7M), TPG GP A, LLC (US$285.7M), Atlas Venture Life Science Advisors, LLC (US$131.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SION
- RA CAPITAL MANAGEMENT, L.P. 9.91M sh · $435.72M · Q2 2026
- TPG GP A, LLC 6.49M sh · $285.71M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 3.00M sh · $131.78M · Q2 2026
- ORBIMED ADVISORS LLC 2.56M sh · $112.43M · Q2 2026
- Enavate Sciences GP, LLC 2.48M sh · $109.01M · Q2 2026
- PERCEPTIVE ADVISORS LLC 905.00K sh · $39.81M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 680.92K sh · $29.95M · Q2 2026
- Siren, L.L.C. 610.51K sh · $26.86M · Q2 2026
- Casdin Capital 400.00K sh · $17.60M · Q2 2026
- Kalehua Capital Management LLC 197.07K sh · $8.67M · Q2 2026
- Sofinnova Investments, Inc. 144.43K sh · $6.35M · Q2 2026
- GordonMD Global Investments LP 136.00K sh · $5.98M · Q2 2026
More on Artia Global Partners LP
FAQ
How long has Artia Global Partners LP held SION?
Artia Global Partners LP has disclosed SION holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Artia Global Partners LP's current position in SION?
As of Q2 2026, Artia Global Partners LP holds 119.74K shares of SION (SIONNA THERAPEUTICS INC), valued at $5.27M, representing 0.97% of its reported portfolio and ranking #26.
Has Artia Global Partners LP been buying or selling SION?
In the latest 13F filing (Q2 2026), Artia Global Partners LP held unchanged its position in SION. The position peaked in Q2 2026 at 119.74K shares.
Which other funds hold SION?
Other major institutional holders of SION include RA CAPITAL MANAGEMENT, L.P., TPG GP A, LLC, Atlas Venture Life Science Advisors, LLC, among 86 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.